Antifibrotic agent 1

CAT: 0931-MF-0115073-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0931-MF-0115073-01Size:10 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Target
C-Fms|||Others|||PDGFR|||Src
Related Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis|||Others
Bioactivity
Antifibrotic agent 1 is an orally active medication designed to treat idiopathic pulmonary fibrosis (IPF) . It effectively mitigates IPF-related processes, including TGF-?-induced epithelial-mesenchymal transition (EMT) and fibroblast-to-myofibroblast transition (FMT), as well as profibrotic M2 polarization. Antifibrotic agent 1 selectively inhibits CSF-1R, PDGFR-?, and Src family kinases (SFKs), while sparing VEGFR, FGFR, and Abl to minimize off-target toxicity. In a bleomycin (BLM) -induced pulmonary fibrosis mouse model, it demonstrates strong antifibrotic activity.
Molecular Formula
C27H23ClN6O2
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
MF-0004083-01Anticonvulsant agent 1
MF-0159413-01Herbicidal agent 1
MF-0013646-01Neuroprotective agent 1
MF-0036505-01Antimicrobial agent-1
MF-0004421-01Antifungal agent 1
MF-0120070-01Antibiofilm agent-1
MF-0100019-01Molluscicidal agent-1
MF-0158381-01Therapeutic agent-1
MF-0146207-01Antitubulin agent 1
MF-0004427-01Antitrypanosomal agent 1

Alternative Products

CatalogName
TBI2307-5MGPirfenidone, Antifibrotic agent
HY-176194Antifibrotic agent 1
HY-177739Antifibrotic agent 2
M36065-01Antiviral agent
HY-163708Antibacterial agent
TBI2469-5GMetformin HCl, Antidiabetic agent / Life extension agent
TBI2429-10MGDaunorubicin HCl, DNA damaging agent; anticancer agent
MBS3614709-01Antitumor agent-19
MBS3615921-01Cryptating agent 222
MBS3617498-01Antimalarial agent 13

Popular Products